Text-Enabled Ascertainment and Community Linkage for Health (TEACH)

January 23, 2023 updated by: Margaret Samuels-Kalow, Massachusetts General Hospital
The goal of this study is to pilot test a novel tool for health related social needs screening and linkage to community resources in the ED by randomizing participants to standard handout v. handout + text message with resource information.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 51 ZIP codes included in our database of community resources ("catchment area")
  • >=18 years old
  • plan for discharge home
  • speak either English or Spanish
  • live within the catchment area for the study
  • have a cellphone with text messaging capabilities
  • ability to respond to text messages from the study team.

Exclusion Criteria:

  • Patients who are intoxicated
  • on a Section 12
  • lack capacity to consent will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Handout
Participants receive a generic handout about resources in Boston
Experimental: Text message
Participants receive a generic handout about resources in Boston and a text message with a geographically proximate resource
Geographically proximate resources delivered by text message

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction: Likert scale
Time Frame: 3-5 days
Participants will be asked about their satisfaction with the program measured on a Likart scale. Options will include "Extremely or Quite a bit; Somewhat; A little bit or Not at all"
3-5 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resource use
Time Frame: 3-5 days
Participants will be asked about actual and planned resource use
3-5 days
Health status
Time Frame: 3-5 days
Participants will be asked about health status. In general, how would you rate your health? Excellent, Very good, Good or Fair,Poor
3-5 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
ED utilization
Time Frame: 30 days
Chart review of ED visits and potentially preventable utilization
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2019

Primary Completion (Actual)

March 1, 2020

Study Completion (Actual)

March 1, 2020

Study Registration Dates

First Submitted

May 17, 2019

First Submitted That Met QC Criteria

August 14, 2019

First Posted (Actual)

August 15, 2019

Study Record Updates

Last Update Posted (Actual)

January 25, 2023

Last Update Submitted That Met QC Criteria

January 23, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019P001579

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergency Medicine

Clinical Trials on Text message information

3
Subscribe